Streetbeat News

Analyst Ratings

CPSI

Cantor Fitzgerald analyst Steven Halper has reiterated an Overweight rating on CPSI (NASDAQ:CPSI) and maintained a $24 price target.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 4:49 pm

DCGO

Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on DocGo (NASDAQ:DCGO) and maintained a $13 price target.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 4:48 pm

LFMD

Cantor Fitzgerald analyst Sarah James maintains an Overweight rating on LifeMD (NASDAQ:LFMD) and raises the price target from $7 to $8.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 4:46 pm

CELH

Roth MKM analyst Sean McGowan has reiterated a 'Buy' rating on Celsius Holdings (NASDAQ:CELH) and maintained a price target of $220.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 4:43 pm

PLUG

Plug Power Inc's (NYSE:PLUG) shares are trading lower following a price target cut from Truist Securities. The analyst lowered the price target from $9 to $8, citing more moderate sequential growth in Q3 due to production timing and electrolyzer shipments more weighted for Q4. The analyst also mentioned potential delays to PTC guidance due to the threat of a government shutdown impacting PLUG's financing efforts. The stock is also facing additional selling pressure due to a breakdown in technical support.

Portfolio Pulse from Adam Eckert

October 02, 2023 | 4:43 pm

PLUG

Truist Securities analyst Jordan Levy has maintained a 'Hold' rating on Plug Power (NASDAQ:PLUG) and lowered the price target from $9 to $8.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 4:40 pm

FEMY

Femasys Inc. (NASDAQ:FEMY) shares have risen by over 14% on Monday and have seen a 900% increase over the last five days. This surge is attributed to HC Wainwright & Co. analyst Emily Bodnar maintaining a Buy rating for Femasys and raising the price target from $5 to $13. Additionally, Femasys announced the activation of enrollment for its FemBloc trial, a permanent birth control candidate.

Portfolio Pulse from Erica Kollmann

October 02, 2023 | 4:37 pm

VKTX

Truist Securities analyst Joon Lee has reiterated a 'Buy' rating on Viking Therapeutics (NASDAQ:VKTX) and maintained a price target of $32.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 4:37 pm

SPOT

Truist Securities analyst Matthew Thornton has reiterated a 'Buy' rating on Spotify Technology (NYSE:SPOT) and maintained a price target of $176.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 4:34 pm

INSP

Truist Securities analyst Richard Newitter has reiterated a 'Buy' rating on Inspire Medical Systems (NYSE:INSP) and maintained a price target of $340.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 4:33 pm